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ABSTRACT
Double-stranded RNA-binding domains (dsRBDs)
are commonly found in modular proteins that inter-
act with RNA. Two varieties of dsRBD exist: canoni-
cal Type A dsRBDs interact with dsRNA, while non-
canonical Type B dsRBDs lack RNA-binding residues
and instead interact with other proteins. In higher
eukaryotes, the microRNA biogenesis enzyme Dicer
forms a 1:1 association with a dsRNA-binding pro-
tein (dsRBP). Human Dicer associates with HIV TAR
RNA-binding protein (TRBP) or protein activator of
PKR (PACT), while Drosophila Dicer-1 associates
with Loquacious (Loqs). In each case, the interac-
tion involves a region of the protein that contains
a Type B dsRBD. All three dsRBPs are reported
to homodimerize, with the Dicer-binding region im-
plicated in self-association. We report that these
dsRBD homodimers display structural asymmetry
and that this unusual self-association mechanism is
conserved from flies to humans. We show that the
core dsRBD is sufficient for homodimerization and
that mutation of a conserved leucine residue abol-
ishes self-association. We attribute differences in the
self-association properties of Loqs, TRBP and PACT
to divergence of the composition of the homodimer-
ization interface. Modifications that make TRBP more
like PACT enhance self-association. These data are
examined in the context of miRNA biogenesis and
the protein/protein interaction properties of Type B
dsRBDs.
INTRODUCTION
Double-stranded (ds) RNA-binding domains (dsRBDs;
also called dsRNA-binding motifs or dsRBMs) are found
in all domains of life, and contribute to diverse biologi-
cal processes ranging from splicing to antiviral responses
(1,2). All dsRBDs adopt a common ---- fold, but
they can be divided into two distinct classes: those that
bind dsRNA and those that do not (3). Type-A dsRBDs
bind dsRNA via three conserved regions. This interaction
rarely displays any speciicity for RNA sequence and is in-
stead dependent on dsRNA-speciic groove structures and
the 2′-OH of the ribose sugar (1). Type B dsRBDs lack
residue conservation in dsRNA recognition regions, includ-
ing two critical lysine residues in dsRNA recognition Re-
gion 3, and consequently cannot bind dsRNA (3). Instead,
Type B dsRBDs have evolved to mediate protein–protein
interactions. While there have been many structural studies
of Type A dsRBDs, only recently has structural informa-
tion about protein–protein interactions mediated by Type
B domains become available.
DsRBDs are commonly found in proteins that con-
tain other RNA-binding or RNA-processing domains,
such as the RNase III domains in Dicer and Drosha,
the kinase domain in interferon-induced, dsRNA-activated
protein kinase (PKR), or the A-to-I deaminase domain
in dsRNA-speciic adenosine deaminase (ADAR). In eu-
karyotes, dsRNA-binding proteins can contain multiple
dsRBDs, either of a single type or a mixture of Type A
and Type B. Sequence similarity between dsRBDs in the
same protein can vary considerably. Studies that have char-
acterized the properties of individual Type A domains from
multi-dsRBD proteins have revealed that they typically
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show different afinities for dsRNA (4–8). These data sug-
gest that multiple dsRBDs offer a convenient way to tune
protein afinity to dsRNA and, through the protein binding
properties of Type B dsRBDs, to interact with other dsRNA
binding proteins.
In microRNA (miRNA) biogenesis, a protein complex
containing a Dicer enzyme processes precursor miRNAs
(pre-miRNAs). Eukaryotic Dicers typically associate with
one or more dsRBD-containing protein. In humans, Dicer
associates with one of two homologous proteins: protein
activator of PKR (PACT) or TAR-RNA binding protein
(TRBP) (9–11). In Drosophila, pre-miRNAs are processed
by Dicer-1, which associates with Loquacious (Loqs), a ho-
mologue of both TRBP and PACT (12).
TRBP, PACT and Loqs contain three dsRBDs, two Type
A and one Type B. All three proteins interact with their re-
spectiveDicers via the Type B dsRBD, which shows high se-
quence conservation across the three proteins (Supplemen-
tary Figure S1) (3,13–15). PACT and TRBP are also impli-
cated in the regulation of PKR, with dsRBD 3 (D3) being
responsible for inhibition in the case of TRBP, and condi-
tional activation in PACT (16–18). Each protein has also
been reported to homodimerize, an interaction mediated by
a region in the C-terminus that contains the Type B dsRBD
(6,19,20). The structural biology of homodimerization of
non-canonical dsRBDs has only recently been interrogated.
Homodimer crystal structures of dsRBDs from HYL1 (7),
Staufen (21) and Loqs (20) have all recently been reported
with each structure proposing a different homodimerization
interface. Knowledge of the dsRBD interfaces and mecha-
nisms that promote homomeric interactions in these pro-
teins is critical as these dsRBDs also mediate heteromeric
interactions with functional binding partners, such as the
interaction of TRBP, PACT and Loqs with Dicer (22) and
the interaction of Staufen with Miranda (23).
Here, we show that homodimerzation of full-length
PACT is mediated exclusively via the Type B dsRBD
(PACT-D3) and that this property is not dependent on
dsRNA. We examine the homodimerization domain and
reveal signiicant structural asymmetry at the homodimer-
ization interface. Nuclear magnetic resonance (NMR) spec-
troscopic analysis and mutagenesis reveal that PACT-D3,
TRBP-D3 and Loqs-D3 all homodimerize using the same
surface andmolecular mechanism. The conserved asymme-
try in the homodimerization of PACT, Loqs and TRBP is
an inherent property of these domains. We show that asym-
metry results from the formation of an inter-molecular par-
allel -sheet, which is stabilized by an inter-strand hydrogen
bonding network that would not be possible in a symmet-
ric parallel dimer. We show that TRBP-D3 dimerizes more
weakly than PACT-D3 but that a two amino acid substi-
tution in TRBP-D3, which makes the homodimerization
interface more PACT-like, stabilizes asymmetric homod-
imerization. To our knowledge, the asymmetric -sheet de-
scribed here is a novel symmetry-breaking motif in homo-
meric protein oligomerization. The same surface forms the
binding site for Dicer (22), suggesting a link between asym-
metric homodimerization in TRBP, PACT and Loqs, and
their role in miRNA biogenesis.
MATERIALS AND METHODS
Plasmid construction
Codon-optimized sequences of PACT and TRBP were or-
dered from GeneArt, and regions corresponding to PACT
residues 239–313 (PACT-D3) and 208–313 (PACT-Ext-D3),
and TRBP residues 258–366 (TRBP-Ext-D3) were cloned
into a vector derived from pET-28a (24) using an In-Fusion
cloning strategy (Clontech). This vector is based on the pET
vector series, and results in attachment of an N-terminal
hexa-histidine tag, maltose binding protein (MBP) and
HRV 3C protease cleavage site. Loqs-D3 (residues 392–463)
was cloned into the pGEX-4T-1 plasmid as described pre-
viously (20). Mutations were introduced using QuikChange
Lightning mutagenesis kits (Agilent).
Protein expression and puriication
Proteins were expressed in Escherichia coli BL21 (DE3)
grown in M9 minimal media containing 15N ammonium
chloride (and 13C glucose for samples used for 3D NMR
experiments). Cultures were grown to an OD600 of 0.6–
0.8 at 37◦C, then induced with 1 mM isopropyl-beta-D-
thiogalactopyranoside and further incubated at 20◦C for 16
h. For PACT-D3, PACT-Ext-D3 and TRBP-Ext-D3, cells
were lysed by sonication or by continuous lowFrench press.
His-MBP-tagged protein was puriied using HisTrap FF
columns (GE Healthcare). The fusion proteins were incu-
bated overnight with His-tagged 3C protease, before be-
ing passed over a HisTrap FF column to remove the tag
and protease. The domain of interest was then further puri-
ied using a Superdex S75 16/60 size exclusion column (GE
Healthcare), equilibrated with 20 mMMES pH 6.5, 50 mM
NaCl, before a inal dialysis against 20 mM MES pH 6.5,
50 mM NaCl, and 5–10 mM TCEP. For Loqs-D3, purii-
cation was as above, except GSTrap columns (GE Health-
care) were used instead of HisTrap FF, tobacco etch virus
protease was used instead of HRV 3C protease, and all pu-
riication steps except size exclusion chromatography were
performed at 4◦C. Protein concentration was determined by
absorbance measurements at 280 nm.
SEC-MALLS
Except where otherwise noted, a Superdex S75 10/30 an-
alytical column (GE Healthcare) was equilibrated with 20
mM MES pH 6.5, 200 mM NaCl, 1 mM dithiothreitol at
a low rate of 0.5 ml/minute. A total of 100 l of protein
sample (at 2–5 mg/ml) was injected, and refractive index
and light scattering proiles were recorded inline using Wy-
att rEX Optilab andWyatt Dawn HELEOS-II instruments.
Data were analysed usingASTRA software version 5.3.4.14
(Wyatt Instruments), using a Zimmmodel. Light scattering
detectors were normalized on a sample of BSA, and dn/dc
chosen in the range 0.164–0.180 to give the correct mass for
BSA. All SEC MALLS experiments of TRBP and PACT
constructs were conducted at least twice.
NMR data
NMR samples were prepared by dialysis into 20 mM
MES pH 6.5, 50 mM NaCl, 5–10 mM TCEP followed
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by the addition of 10% D2O and 50 M 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS). The 2D (1H, 15N)HSQC
and EXSY spectra, and 3D experiments for assignment of
PACT-D3 L273R, were recorded using a Bruker Avance
II 700 MHz spectrometer with a triple-resonance room
temperature probe. Spectra for backbone assignment of
wild-type (WT) PACT-D3 were recorded on a Bruker 600
MHz Avance II+ spectrometer with triple-resonance cry-
oprobe, while spectra for side-chain assignment was col-
lected on a Bruker 800 MHz Avance III HD spectrometer
with triple-resonance cryoprobe. The 13Cilter-editNOESY
experiment was recorded on a 50:50 mixture of [13C,15N]-
and [15N]-labelled WT PACT-D3 using a Bruker 700 MHz
Avance IIIHD spectrometerwith quadruple-resonance cry-
oprobe. The high pressure 2D (1H, 15N) HSQC NMR ex-
periments were recorded using a Bruker 800 MHz Avance I
spectrometer, equipped with a triple-resonance room tem-
perature probe. The sample was inserted into a ceramic tube
(rated to 2.5 kbar) and pressurized with parafin oil (Sigma)
using a high-pressure syringe pump (Daedalus Innovations
LLC, PA).
NMR data analysis
Spectra were processed with either TopSpin (Bruker) or
NMRPipe (25). Assignment of PACT-D3 backbone and
sidechain resonances, and peak picking of EXSY spec-
tra, was performed with CCPNMR Analysis V2 (26). A
‘compound’ chemical shift difference was calculated as√
δ2H + (δN/6.5)
2). EXSY data were analysed using a ra-
tio of auto- and crosspeak intensities (see Supplementary
Data) (27).
Modelling and structural analysis
The structural model of PACT-D3 was generated using the
I-TASSER server (28). Analysis of the surface buried upon
dimerization of Loqs-D3 was performed using the POPS
server, and averaged between the two dimer subunits (29).
RESULTS
The mechanism of homodimerization of PACT-D3 and Loqs-
D3 is equivalent
Modular, multidomain proteins can often be dissected into
isolated functional units. TRBP, Loqs and PACT have
been reported to have both dsRNA and protein–protein
binding properties, with these activities principally map-
ping to dsRBDs 1 and 2, and dsRBD 3, respectively. We
produced a series of constructs of PACT to explore the
structure/function proile of the protein and determined
their oligomeric state and pre-miRNA binding properties.
We conducted size exclusion chromatography with inline
multi-angle laser light scattering (SEC-MALLS), which
showed that full length (FL) PACT is a homodimer in so-
lution (Supplementary Figure S2A). Homodimerization is
dependent on dsRBD 3, as a construct lacking this do-
main (PACT-D12) eluted with a mass consistent with a
monomer (Supplementary Figure S2B). Furthermore, an
Figure 1. Homodimerization of PACT is mediated exclusively via domain
3. (A) SEC-MALLS results for PACT and Loqs domain 3 constructs. WT
domains are shown in black, mutants are shown in red. The calculated
molecular mass at the peak centre is displayed next to each peak. (B) Sum-
mary of oligomeric states of single- and multi-domain PACT constructs
(see also Supplementary Figure S2).
analysis of the pre-miRNA binding properties of PACT us-
ing electrophoretic mobility shift assays (EMSA) revealed
that dsRNA binding mapped exclusively to dsRBDs 1 and
2, consistent with previous studies of PACT (30,31). FL
PACT and PACT-D12, but not PACT-D3, were able to bind
pre-miR-155 (Supplementary Figure S2C).
The homodimer structure of Drosophila Staufen-D5 re-
vealed that a 20 residue region N-terminal to the dsRBD
was required for homodimerization (21). TRBP and PACT
have a highly conserved 15-residue region N-terminal to
dsRBD 3 (Supplementary Figure S1). We examined the
contribution of this region to the dimerization properties
of PACT. Both the core dsRBD (PACT-D3) and a construct
containing the conservedN-terminal extension (PACT-Ext-
D3) eluted with masses consistent with homodimers (Fig-
ure 1A). DsRBD 3 in Loqs is also preceded by an N-
terminal extension, which shows some sequence conser-
vation to PACT and TRBP (Supplementary Figure S1).
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Figure 2. PACT-D3 has two distinct states in solution. (A–C) (1H, 15N)-
HSQC spectra of (A) WT PACT-D3, (B) PACT-D3 L273R, or (C) both,
with selected assignments. (D) EXSY spectrum ofWT PACT-D3. Selected
sets of auto and exchange peaks are linked with dotted lines.
However, like PACT-D3, Loqs-D3 eluted with a molecu-
lar weight consistent with a homodimer (Figure 1A). These
data are consistent with a homodimer observed in the re-
cent crystal structure of the core dsRBD of domain 3 of
Loqs (20).
Homodimerization of a construct containing Loqs-D3
could be disrupted by a single point mutation (L426R)
on the homodimer interface (20). The equivalent muta-
tion in PACT (L273R) abolished homodimerization in both
PACT-D3 and PACT-Ext-D3, showing that the presence of
theN-terminal region does not compensate formutations in
the dsRBD core (Figure 1A). ThemutationY305A also dis-
rupted homodimerization of PACT-D3, consistent with the
location of this conserved tyrosine at the homodimer inter-
face, but a number of other mutations on the same surface
did not (data not shown). Taken together, these solution
studies show that the core dsRBD fold of domain 3 in both
Loqs and PACT is necessary and suficient for homodimer-
ization (Figure 1B), and suggest that PACT-D3 and Loqs-
D3 share a common mechanism of homodimerization.
Two different states of PACT-D3 are present in solution
NMR spectroscopy was used to further characterize ho-
modimerization of PACT-D3. Following resonance as-
signment (see Supplementary Methods), we observed that
NMR spectra of WT PACT-D3 contained two signals per
site (Figure 2A and Supplementary Figure S3A), indicating
that at least two distinct states are present in solution (arbi-
trarily named A and B). By contrast, spectra of PACT-D3
L273R contained only one signal per site (Figure 2B and
Supplementary Figure S3B). Approximately twice the ex-
pected number of cross peaks were also observed in NMR
spectra of WT PACT-Ext-D3 and WT Loqs-D3, while the
monomeric mutant forms of both constructs gave closer to
the expected number of signals (Supplementary Figure S4).
Analysis of backbone chemical shifts in WT PACT-D3
using TALOS-N (32) showed no signiicant differences in
secondary structure between states A and B (Supplemen-
tary Figure S3C).Moreover, the relative intensities of peaks
in a 2D (1H,15N) correlation spectra were approximately
equal, indicating that the two states are equally populated.
This observation was true for a range of conditions, includ-
ing high pressure (2.5 kbar), low concentration of denatu-
rant (2.5 M urea) and across a range of temperatures (Sup-
plementary Figure S3D).
We used 2D heteronuclear NMR exchange spectroscopy
(EXSY) to determine whether the two states of WT PACT-
D3 are in exchange with one another. With a mixing time
of 0.5 s, exchange cross peaks were observed for almost all
residues (Figure 2D and Supplementary Figure S5A), sug-
gesting a global exchange process. A series of 2D EXSY
spectra was used to calculate a global exchange rate of 0.71
s−1, with a 95% conidence interval of (0.65 s−1, 0.86 s−1),
assuming equal populations of the two states (Supplemen-
tary Figure S5B).
PACT-D3 homodimers are asymmetric
We ruled out a number of potential explanations for the two
states of WT PACT-D3 that were observed in NMR spec-
tra (see Supplementary Table S1), which left two plausible
explanations: the two sets of signals could originate from
two different homodimeric forms ofWT PACT-D3, both of
which are symmetric; or WT PACT-D3 could form a single
asymmetric homodimer, with each half of the dimer giving
rise to a separate set of signals in NMR spectra.
To distinguish conclusively between these possibilities,
we prepared a sample containing equimolar amounts of
natural abundance, and [13C,15N]-labelled PACT-D3, and
recorded a 13C-iltered NOESY NMR experiment (Supple-
mentary Figure S6). This NMR experiment detects NOEs
of intermolecular origin thereby allowing direct identiica-
tion of sites at the homodimer interface. Moreover, this ex-
periment can distinguish symmetric versus asymmetric ho-
modimerization: in a symmetric homodimer, intermolecu-
lar NOEs would only be observed between nuclei of the
same state (i.e. only A to A or B to B), while an asymmet-
ric homodimer would have NOEs linking the two different
states (i.e. only A to B or B to A). 1H-1H NOE cross peaks
were observed between one of the  -methyl groups of V283
in state A, and the  2-methyl group of T282 in state B (Fig-
ure 3A and Supplementary Figure S6C) and between one
of the -methyl groups of L273 in state A and the - and -
protons of Q304 and Y305 in state B (Supplementary Fig-
ure S6D). These NOE correlations would only be possible
if WT PACT-D3 forms an asymmetric homodimer.
The 3D structure of Loqs-D3 was initially described as
forming a symmetric homodimer (20), but in light of the
NMR-based data presented here, re-inspection of the struc-
ture revealed that the protomers in fact associate to form
an asymmetric homodimer (SupplementaryFigure S7). The
equivalent residues of L273, V283, Q304 and Y305 in Loqs
are located at this asymmetric interface (Figure 3B). Par-
tial assignment of a number of 13C-iltered NOESY signals
originating from the -sheet and C-terminal -helix indi-
cate that they are also located on the homodimer interface
Nucleic Acids Research, 2017 5
Figure 3. Homodimerization of PACT-D3 involves the same interface as
Loqs-D3. (A) 2D (1H,1H) planes from the 3D 13C-iltered NOESYHSQC
spectrumof PACT-D3 showing an intermolecularNOEbetween one of the
 methyl groups from V283A and the 2 methyl group of T282B. (B) In
the 3D structure of Loqs-D3, residues equivalent to PACT L273 and V283
in state A (red) form intermolecular contacts with residues equivalent to
T282, Q304 and Y305 in state B (blue). (C) Interface atoms in PACT-D3
identiied from the 3D 13C-iltered NOESYHSQC spectrum (red spheres)
displayed on a 3Dmodel of PACT-D3. (D) Interface of Loqs-D3 displayed
on a single subunit as the proportion of solvent accessible surface area
(SASA) which is buried upon homodimerization. (E) Compound chemical
shift differences of the backbone amides between the two states of WT
PACT-D3, mapped onto a structural model. Red indicates residues with
low chemical shift changes, yellow and white indicate larger shifts. Panels
C and E show a model of PACT-D3 generated using I-TASSER.
(Figure 3C). These data further support the conclusion that
PACT-D3 homodimerizes via the same interface that was
identiied in the Loqs-D3 homodimer (Figure 3D) and that
this association forms an asymmetric homodimer.
Asymmetry is localized to the homodimer interface
The degree of asymmetry of PACT-D3 homodimers at a
given location can be qualitatively described by the chem-
ical shift difference between equivalent nuclei in the two
states. Plotting these values on a structural model of PACT-
D3 revealed that the greatest differences occur on strand
3 and the C-terminal half of helix 2. Smaller differences
are visible on the other -strands (Figure 3E). The largest
chemical shift differences occur at residues V283 and H285.
Overall, the most signiicant chemical shift differences oc-
cur predominantly at the homodimer interface, and, given
the similar TALOS-N proiles of the two states, these chem-
ical shift differences are unlikely to be caused by conforma-
tional changes in other parts of the protein.
In Loqs-D3, V436 and H438 lie at the homodimer inter-
face, where they form part of an inter-subunit parallel -
sheet. Analysis of the 3D structure of Loqs-D3 shows that
the two -strands at the interface are shifted with respect to
each other. This coniguration breaks the symmetry but al-
lows the formation of intermolecular inter-strand hydrogen
bonds: V436A forms hydrogen bonds to V436B and H438B,
while V436B is bonded to V434A and V436A (Figure 4A
and B). The equivalent residues of V436 andH438 in PACT
are V283 and H285. To determine whether PACT-D3 ho-
modimerizes via a similar mechanism, we recorded 3D 15N-
NOESY-HSQC spectra of WT PACT-D3. We found a net-
work of NOEs that is consistent with a parallel -sheet in-
terface and a similar shift in strand register: the amide pro-
tons of V283A and H285B in PACT are in close proximity,
but this is not the case for V283B and H285A (Figure 4C).
A PACT-like variant of TRBP-D3 forms a stronger homod-
imer
The dimerization interface inWT PACT-D3 andWTLoqs-
D3 is well conserved in TRBP-D3 (Supplementary Figure
S1), and it would therefore be expected that they display
similar homodimerization behaviour. However, although
full-length TRBP has been shown to homodimerize, a sepa-
rate study found that TRBP-D3 did not form homodimers
(6,19). To further evaluate the homodimerization proper-
ties of TRBP, we expressed and puriied a construct con-
taining dsRBD 3 and the N-terminal extension (TRBP-
Ext-D3). SEC-MALLS analysis of TRBP-Ext-D3 yielded
a chromatogram with a single peak with a mass ∼1.5 times
that expected for a monomer (Figure 5A). NMR spectra of
TRBP-Ext-D3 are characterized by broad line widths, and
show considerably less than the expected number of peaks,
features which are indicative of exchange broadening (Sup-
plementary Figure S8A). These data indicate that TRBP-
Ext-D3 is in monomer/homodimer equilibrium and that
it homodimerizes with lower afinity than PACT-D3 and
Loqs-D3.
Closer examination of the Loqs-D3 homodimer interface
revealed two residues (Q453, N454) that are exposed on one
protomer, but form part of the interface on the other (Fig-
ure 5B and C). The equivalent residues in PACT-D3 retain
similar chemical properties (H300, N301), but in TRBP-
D3 they are replaced by arginines (R353, R354). To test
whether these differences are responsible for the lower ho-
modimerization afinity of TRBP-Ext-D3, we substituted
the two arginine residues with the equivalent residues in
PACT-D3. The resulting PACT-like variant of TRBP-Ext-
D3 was homodimeric, as assessed by SEC-MALLS (Fig-
ure 5A). Moreover, NMR spectra of this R353H,R354N
TRBP-Ext-D3 construct showed signiicantly more than
the expected number of peaks (Supplementary Figure S8B).
By contrast, the L326R variant of TRBP-Ext-D3 (the
equivalent of Loqs-3 L426Rmutation) was monomeric and
gave rise to a single set of NMR peaks (Figure 5A and
Supplementary Figure S8C). These data are consistent with
TRBP-Ext-D3 dimerizing via the same asymmetric inter-
face as PACT-D3 and Loqs-D3, with the presence of R353
and R354 residues causing the reduced homodimerization
afinity.
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Figure 4. Asymmetric homodimerization forms an inter-subunit parallel
-sheet. (A) Upper: symmetric homodimer interfaces cannot involve par-
allel -strands because the symmetry axis (dashed line) prevents alignment
of hydrogen bond donors and acceptors. Lower: offsetting the -strands
allows the formation of hydrogen bonds, but breaks the symmetry. (B)
Close-up of the Loqs-D3 homodimer interface surrounding V436. Hy-
drogen bonds are shown as dashed red lines, while predicted NOEs are
shown as black dotted lines. (C) Planes from a 3D 15N-NOESY-HSQC of
PACT-D3, showing that NOEs are detected between the backbone amides
of V283A and H285B (peaks marked by dotted lines) but not V283B and
H285A (empty squares). Cross peaks marked * are due to chemical ex-
change, and do not necessarily imply proximity. The contour levels are
identical in all strips.
DISCUSSION
Homodimers are the simplest form of protein complex, and
account for around 60% of homomeric complexes in the
3D complex database (33). Althoughmany homodimers ex-
hibit some limited local asymmetry, a recent survey found
that 90% were globally symmetric (34). Of the remaining
structures, 5% exhibited partial asymmetry while only 5%
were grossly asymmetric. The heavy bias in favour of sym-
metry is likely due to a number of factors. For example, sym-
metric organizations guarantee inite assembly as each sub-
unit has an interface that is satisied by homomeric associ-
ation. This prevents formation of higher oligomers such as
ibrils (35). In addition, homo-oligomers can also evolve in
fewer steps, as each mutation that forms a new favourable
interaction is reciprocated by the other subunit, which re-
sults in two new interactions overall (36,37). This picture
is supported by several computational studies using either
idealized interfaces or docking of real protein structures
(38,39). It is also possible that structural data of asymmetric
homomeric complexes might be under-represented due to
technical challenges. Asymmetric homodimerization places
each nucleus in two distinct chemical environments, leading
to peak doubling inNMRspectra, which confounds the elu-
cidation of the 3D structure viaNOEmeasurements. Asym-
metric association of protomers may also disfavour the for-
mation of diffraction-quality protein crystals. These effects
would likely reduce the number of 3D structures of asym-
metric homodimers deposited in the PDB.
There are myriad ways to break symmetry in a macro-
molecular assembly. On a molecular level, differences in ro-
tameric states mean that protein subunits are unlikely to
ever achieve perfect symmetry. On a more macromolec-
ular level, gross asymmetry can be caused when a sym-
metric homomer interacts with an odd number of ligands
(34). In such cases, asymmetry arises due to a symmetry
mismatch between the ligand(s) and homomeric receptor.
Other assemblies have been found to exhibit asymmetry
based around simple motifs, such as register slips in an-
tiparallel -strands or coiled coils (40). None of these ex-
planations accounts for homodimerization of PACT, TRBP
and Loqs, where the asymmetric association causes a regis-
ter shift between parallel -strands at the homodimer in-
terface (Figure 4A). Backbone hydrogen bonding between
equivalent parallel -strands can only occur in an asymmet-
ric homodimer, as symmetric association would cause mis-
alignment of backbone hydrogen bond donors and accep-
tors (Figure 4A). This asymmetric -sheet motif of TRBP,
PACT and Loqs appears to represent a previously unob-
servedmethod of symmetry-breaking in homomeric protein
oligomers.
The presence of asymmetry in PACT, TRBP and Loqs
homodimersmeans that, for a given protomer, there are two
possible ways the second protomer can associate to form a
homodimer. Association occurs via two different, but over-
lapping, interfaces (Supplementary Figure S7). In this case,
the overlap of these interfaces prevents the formation of un-
bounded ibrils. By way of contrast, the putative dimeriza-
tion interface reported for dsRBD 2 of HYL1 is asymmet-
ric but without overlap, which would allow the assembly of
non-inite ibrils (7).
The homodimerization interface of dsRBD 3 of PACT,
TRBP and Loqs is conserved in vertebrates, insects and
molluscs (SupplementaryFigure S1) and, as such, the asym-
metric mechanism of association is likely to have been
present in the last common ancestor of these species, at least
580 million years ago (41). In particular, the leucine residue
at position 273 in PACT, whose mutation to arginine pre-
vents homodimerization, is conserved in all sequences ex-
amined. The conservation at the interface strongly suggests
a functional relevance for the asymmetric homodimeriza-
tion seen in these proteins.
DsRBD 3 of PACT, TRBP and Loqs associates with the
helicase insert (Ins) domain of Dicer. Residues that form
the Dicer binding interface of TRBP-D3 are well conserved
in PACT-D3 and Loqs-D3: TRBP to PACT shows 69%
sequence identity; while TRBP to Loqs is 59% (Supple-
mentary Figure S9). It is therefore likely that both Loqs
and PACT interact with their respective Dicers in a sim-
ilar manner to that previously revealed by the 3D struc-
ture of the Dicer-TRBP interface (22). In support of this
statement, mutation of Dicer prevented interactions with
both TRBP and PACT (22). One key difference between the
-sheet surface of PACT, TRBP and Loqs is that TRBP
has two positively charged residues (R353, R354) where
Loqs and PACT have polar residues (Q453 and N454, or
H300 and N301, respectively). Mutating the two arginine
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Figure 5. Homodimerization of TRBP-D3 is disfavoured by arginines
353 and 354 at the homodimer interface. (A) SEC-MALLS proiles of
TRBP-Ext-D3 (black), L326R (red) andR353H, R354N (blue). The single
peak of intermediate calculated mass for TRBP-Ext-D3 indicates that the
monomer and homodimer forms exchange at a rate faster than approxi-
mately 10−3 s−1. (B) Q453 and N454 of Loqs-D3 protomer A (red) are not
in direct contact with protomer B (blue). (C) By contrast, Q453 and N454
of Loqs-D3 protomer B are in direct contact with protomer A.
residues in TRBP to make them PACT-like increased the
stability of the TRBP-D3 homodimer. The 3D structure of
the TRBP-Ext-D3/Dicer-Ins complex revealed that R354
of TRBP forms an intermolecular salt bridge with E278 in
Dicer (22). A glutamate or aspartate is present at this posi-
tion in most mammalian Dicers whereasDrosophilaDicer1
has no equivalent negative charge in this region. These data
suggest that TRBP may have evolved residues that promote
interaction with Dicer over homodimerization. Indeed, dif-
ferences in afinities of homodimerization between TRBP
and PACT have been suggested to have implications on how
they interact with dsRNA (31). Such differences could po-
tentially allow Dicer to discriminate between dsRNA sub-
strates bound to TRBP and those bound to PACT.
Outside of miRNA processing, knowledge of the struc-
tural biology of the protein binding properties of non-
canonical Type B dsRBDs has been limited to studies of
Staufen fromDrosophila and human. Homodimer and het-
erodimer structures of the ifth dsRBD of Staufen (Staufen-
D5) have been reported (21,23). There is limited amino acid
conservation between D3 of TRBP, PACT and Loqs and
Staufen-D5––only the core structural residues that deine
the dsRBD fold are conserved. However, these domains are
all Type B dsRBDs and lack residues related to dsRNA
binding.
Staufen-D5 forms a symmetric homodimer, which is
mediated by a domain-swap mechanism involving an N-
terminal extension to the core dsRBD structure (21). PACT,
TRBP and Loqs all have a 15-residue element N-terminal
to D3. However, our data conclusively show that this N-
terminal extension is not required for homodimerization.
The 3D structure of a Staufen-D5/Miranda complex re-
vealed differences between how this domain homo- and
heterodimerizes (23). Staufen-D5 interacts with Miranda
via the 3-stranded -sheet of the dsRBD. While this is the
same surface involved in TRBP, PACT and Loqs homod-
imerization, and the interaction between TRBP and Dicer,
there is only limited conservation of surface residues be-
tween the three Dicer cofactors and Staufen-D5. That said,
mutation of isoleucine 982 to alanine in Staufen-D5, the
equivalent residue of L273 in PACT, L326 in TRBP and
L426 in Loqs, prevented interaction withMiranda (23). To-
gether, these data suggest that unrelated Type B dsRBDs
may have evolved different and context-dependent mech-
anisms for forming protein–protein interactions. However,
the -sheet of dsRBDs forms part of the interface in three
of the four complexes of known 3D structure and so it is
plausible that this region has properties particularly suited
to protein–protein interactions.
Here, we have shown that the Type B dsRBD that medi-
ates interactions betweenDicer and its pre-miRNA-binding
cofactors forms an asymmetric homodimer and that this
asymmetry is conserved fromDrosophila to humans. Asym-
metric association causes a register shift between the paral-
lel -3 strands, which permits the formation of intermolec-
ular inter--strand hydrogen bonds. We identiied differ-
ences in residue composition of the homodimer interfaces
of these Dicer co-factors and showed that mutation of the
interface of TRBP to make it more PACT- and Loqs-like
enhances homodimerization. These data reveal a rare but
conserved example of asymmetric homomeric association,
which sheds light on the co-evolution of Dicer and its co-
factors.
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